1-12 of 12
Eveline P. Mauser-Bunschoten
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

New concepts for anticoagulant therapy in persons with hemophilia

Roger E. G. Schutgens, Jeroen F. van der Heijden, Eveline P. Mauser-Bunschoten, Pier M. Mannucci
Journal: Blood
Blood (2016) 128 (20): 2471–2474.
https://doi.org/10.1182/blood-2016-07-727032
Published: 2016
Journal Articles

von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease

Clinical Trials & Observations
Yvonne V. Sanders, Dafna Groeneveld, Karina Meijer, Karin Fijnvandraat, Marjon H. Cnossen, Johanna G. van der Bom, M. Coppens, Joke de Meris, Britta A. P. Laros-van Gorkom, Eveline P. Mauser-Bunschoten, Frank W. G. Leebeek, Jeroen Eikenboom, the WiN study group
Journal: Blood
Blood (2015) 125 (19): 3006–3013.
https://doi.org/10.1182/blood-2014-09-603241
Published: 2015
Includes: Supplemental data
Journal Articles

Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trial

Clinical Trials & Observations
Peter W. Collins, Guy Young, Karin Knobe, Faraizah Abdul Karim, Pantep Angchaisuksiri, Claus Banner, Türkiz Gürsel, Johnny Mahlangu, Tadashi Matsushita, Eveline P. Mauser-Bunschoten, Johannes Oldenburg, Christopher E. Walsh, Claude Negrier
Journal: Blood
Blood (2014) 124 (26): 3880–3886.
https://doi.org/10.1182/blood-2014-05-573055
Published: 2014
Includes: Supplemental data
Journal Articles

Willebrand in the Netherlands: WiN Study. Background and Study Design

Eva M. De Wee, MD, Eveline P. Mauser-Bunschoten, MD, PhD, Anske G. Van der Bom, PhD, Jeroen C.J. Eikenboom, MD, PhD, Karin J. Fijn van Draat, MD, PhD, Arja De Goede-Bolder, MD, Karina Meijer, MD, PhD, Irena Nováková, MD, PhD, Iris Plug, PhD, Frank W.G. Leebeek, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 4510.
https://doi.org/10.1182/blood.V112.11.4510.4510
Published: 2008
Journal Articles

Social participation of patients with hemophilia in the Netherlands

Clinical Trials & Observations
Iris Plug, Marjolein Peters, Eveline P. Mauser-Bunschoten, Arja de Goede-Bolder, Lily Heijnen, Cees Smit, José Willemse, Frits R. Rosendaal, Johanna G. van der Bom
Journal: Blood
Blood (2008) 111 (4): 1811–1815.
https://doi.org/10.1182/blood-2007-07-102202
Published: 2008
Journal Articles

Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study

Clinical Trials & Observations
Dirk Posthouwer, Michael Makris, Thynn T. Yee, Kathelijn Fischer, Joost J. van Veen, Anja Griffioen, Karel J. van Erpecum, Eveline P. Mauser-Bunschoten
Journal: Blood
Blood (2007) 109 (9): 3667–3671.
https://doi.org/10.1182/blood-2006-08-038349
Published: 2007
Journal Articles

Bleeding in carriers of hemophilia

Clinical Trials & Observations
Iris Plug, Eveline P. Mauser-Bunschoten, Annette H. J. T. Bröcker-Vriends, Hans Kristian Ploos van Amstel, Johanna G. van der Bom, Joanna E. M. van Diemen-Homan, José Willemse, Frits R. Rosendaal
Journal: Blood
Blood (2006) 108 (1): 52–56.
https://doi.org/10.1182/blood-2005-09-3879
Published: 2006
Journal Articles

Successful treatment of severe bleeding in hemophilic target joints by selective angiographic embolization

Clinical Trials & Observations
Eveline P. Mauser-Bunschoten, Jacco A. C. Zijl, Willem Mali, A. Cees van Rinsum, H. Marijke van den Berg, Goris Roosendaal
Journal: Blood
Blood (2005) 105 (7): 2654–2657.
https://doi.org/10.1182/blood-2004-06-2063
Published: 2005
Journal Articles

Factor VIII Half-Life and Clinical Characteristics of Severe Hemophilia A.

Karin van Dijk, MD, Johanna G. van der Bom, MD, PhD, Eveline P. Mauser-Bunschoten, MD, PhD, Goris Roosendaal, MD, PhD, Peter J. Lenting, PhD, Philip G. de Groot, PhD, H. Marijke van den Berg, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 3091.
https://doi.org/10.1182/blood.V104.11.3091.3091
Published: 2004
Journal Articles

Variability in Bleeding Pattern of Severe Hemophilia.

Karin van Dijk, MD, Kathelijn Fischer, MD, PhD, Johanna G. van der Bom, MD, PhD, Eveline P. Mauser-Bunschoten, MD, PhD, Goris Roosendaal, MD, PhD, H. Marijke van den Berg, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 3094.
https://doi.org/10.1182/blood.V104.11.3094.3094
Published: 2004
Journal Articles

The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia

Clinical Trials & Observations
Kathelijn Fischer, Johanna G. van der Bom, Eveline P. Mauser-Bunschoten, Goris Roosendaal, Robert Prejs, Piet de Kleijn, Diederick E. Grobbee, Marijke van den Berg
Journal: Blood
Blood (2002) 99 (7): 2337–2341.
https://doi.org/10.1182/blood.V99.7.2337
Published: 2002
Journal Articles

Hepatitis G Virus RNA and Hepatitis G Virus-E2 Antibodies in Dutch Hemophilia Patients in Relation to Transfusion History

Eveline P. Mauser-Bunschoten, Marjolein Damen, Hans L. Zaaijer, Margret Sjerps, Goris Roosendaal, P. Nico Lelie, H. Theo M. Cuypers, H. Marijke van den Berg
Journal: Blood
Blood (1998) 92 (6): 2164–2168.
https://doi.org/10.1182/blood.V92.6.2164
Published: 1998